SA
TXG icon

Sanctuary Advisors’s 10x Genomics TXG Stock Holding History

Sanctuary Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,778
Closed -$208K – 2452
2025
Q1 		$208K Sell
23,778
-655
-3% -$8.26K ﹤0.01% 2019
2024
Q4 		$368K Buy
24,433
+6,474
+36% +$102K ﹤0.01% 1876
2024
Q3 		$257K Buy
+17,959
New +$371K ﹤0.01% 2095

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sanctuary Advisors's TXG Position: Q2 2025 in Review

Sanctuary Advisors sold out of 10x Genomics (TXG) in Q2 2025, closing a stake of 23,778 shares — an estimated $208K sold.

Sanctuary Advisors first reported a position in TXG in Q3 2024 and held it in 3 quarters. The position peaked at $368K in Q4 2024. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • Sanctuary Advisors reported no remaining 10x Genomics position as of Q2 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 23,778 10x Genomics shares in Q2 2025, an estimated $208K.
  • Sanctuary Advisors first reported a position in 10x Genomics in Q3 2024 and held it in 3 quarters.
  • Sanctuary Advisors's 10x Genomics position peaked at $368K in Q4 2024.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on Sanctuary Advisors's 13F filing for Q2 2025, filed 6 Jan 2026.